The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium
about
Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformationEpigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppressionA Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation.Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirusUp-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitroRole of virus receptor Hyal2 in oncogenic transformation of rodent fibroblasts by sheep betaretrovirus env proteinsInhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3BSemaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effectEvidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell linesCACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrityExpression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivoLoss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancerTeen smoking, field cancerization, and a "critical period" hypothesis for lung cancer susceptibility.Amino acid management in cancerMitochondria, calcium, and tumor suppressor Fus1: At the crossroad of cancer, inflammation, and autoimmunityVoltage-gated ion channels in cancer cell proliferationRegulation of mTORC1 by amino acidsA conserved coatomer-related complex containing Sec13 and Seh1 dynamically associates with the vacuole in Saccharomyces cerevisiae.A genome-wide screen for regulators of TORC1 in response to amino acid starvation reveals a conserved Npr2/3 complexBiology and therapy of inherited retinal degenerative disease: insights from mouse modelsHigh-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele lossChromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features.A novel radioprotective function for the mitochondrial tumor suppressor protein Fus1BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasionPhase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humansThe tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent mannerTUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug AuranofinA RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.The Ras-association domain family (RASSF) members and their role in human tumourigenesis.Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasisGene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival.High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer.Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer.NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway.Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer.RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers.Cripto haploinsufficiency affects in vivo colon tumor development
P2860
Q24291109-BB2BF90E-8EC8-4A02-BE7A-5D7A98CC15ABQ24291194-A37A51F5-0BE5-4102-B6E6-12E31DF83E67Q24294219-9D10AD21-EFCA-40AF-A93A-D2382B796C5DQ24297959-E5B5FD96-71CA-4827-A006-6B60CD01F4A2Q24299361-A7755AA4-E3C4-4B1E-80E2-93206553A7EBQ24321236-FDFD4BD6-CA2F-432B-89DE-5053582BE055Q24336517-61698E8C-C662-4F82-9ABE-6F8F86CDCB11Q24550690-5C5B9AF1-2D2E-471D-87E3-CEA4C9349A5CQ24555083-F612FBEA-6D71-4EA7-93C8-BF4479429D31Q24564247-72440818-3B9C-4B1F-975B-C67FA9231CDFQ24611593-6EE898F9-0354-4D4C-B677-08F516B7E7EEQ24621344-E6A55CB1-2EC5-4E76-8314-FEC0D025C6FEQ24625463-B11CEA2C-069A-4ACB-8AAA-F72B7B7730F2Q24632794-D307FE2A-D899-4D82-A503-CB2A7B6F7CB8Q24816722-99B301CC-DF96-4E8C-96D0-5F97925684F7Q26798087-9A09322F-E2C2-40FF-855A-FF89FED8C8A0Q26798304-47E43AED-5585-4783-89B0-42C95ED87A75Q27010511-C8FD0DCB-FC30-4DC9-B967-71B4B45ED399Q27025586-4DCE3C74-B025-43C7-97CD-727BBBB10DC6Q27937665-D86CF4EF-12AA-4154-ACDE-945EAC5F5F21Q27938995-37BF27EB-98E3-4E21-85DB-AC706200BEA0Q28084726-AB1C0B06-DF6E-43B6-AC23-FCDB96E5A2D5Q28343524-4C8FD022-DDCD-4308-99D4-FD977A1DD39EQ28360494-68A55C12-43BF-4F46-907A-D044B9661EADQ28385220-1C2B1772-A9A7-4C1F-8196-AC9E7A0A5D4FQ28387249-B8CC8365-C101-43A5-9617-15FADD03CDA0Q28482937-97DB852A-BB56-4360-A4DD-3EB2A7B83CFEQ28534476-02E550E4-AF67-4505-A9FE-89E0003BE855Q28595756-23FCAB53-81D7-4701-8CE6-45CCC3C0ECD0Q30413809-DFD97CCC-7A54-4BF8-93EB-051C83C694D8Q31121564-59F55F25-B06E-4E21-89AA-BC9CD25052DBQ33210156-7DAD9D1F-6655-4526-A372-B549FD35190BQ33320978-14C4F927-CED3-4C7F-A3AA-31788A55A26DQ33455585-1EF3751D-8A9C-4632-8998-E535ACAE9A06Q33535501-92B5E511-9B59-4F1E-972E-5707ECF25587Q33631419-946B274C-B338-452E-A401-DA6A28197FBBQ33654122-D787440B-5804-4BC2-9E9B-B9888BF23D47Q33688815-E45D3774-DCED-4491-9A74-8BB5B9EA26F4Q33708522-011AC597-A8C2-4D30-AEB6-1CAA363B0957Q33836502-BE79ABD9-9091-4659-9E3E-B3EEA2DB4BB9
P2860
The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The 630-kb lung cancer homozyg ...... mor Suppressor Gene Consortium
@ast
The 630-kb lung cancer homozyg ...... mor Suppressor Gene Consortium
@en
The 630-kb lung cancer homozyg ...... mor Suppressor Gene Consortium
@nl
type
label
The 630-kb lung cancer homozyg ...... mor Suppressor Gene Consortium
@ast
The 630-kb lung cancer homozyg ...... mor Suppressor Gene Consortium
@en
The 630-kb lung cancer homozyg ...... mor Suppressor Gene Consortium
@nl
prefLabel
The 630-kb lung cancer homozyg ...... mor Suppressor Gene Consortium
@ast
The 630-kb lung cancer homozyg ...... mor Suppressor Gene Consortium
@en
The 630-kb lung cancer homozyg ...... mor Suppressor Gene Consortium
@nl
P3181
P1433
P1476
The 630-kb lung cancer homozyg ...... mor Suppressor Gene Consortium
@en
P2093
P304
P3181
P407
P577
2000-11-01T00:00:00Z